Screening of cervical hpv infection at the reproductive health centre of ariana
##plugins.themes.academic_pro.article.main##
Abstract
Background: Cervical cancer is the leading cause of cancer mortality among women in developing countries. Over 99 per cent of cases are linked to genital infection with Human Papillomaviruses (HPVs), which are the most common sexually-transmitted viruses worldwide and infect an estimated 660 million people. In light of the advances of the development of HPV vaccines in the world, the challenges to introducing and sustaining such vaccines in the public sector are faced by our countries, generating the need of understanding the local epidemiology of the disease.
aim : This study aims to obtain some relevant data on local disease burden in a big health care centre of Tunis.
method : In this study, 133 healthy Tunisian women are screened for HPV infection with detection of 37 genotypes. Samples are collected on dry cotton swabs and genotyping use PCR and linear array assay.
results : 7,8 % of women were infected and HPV 16 was the only High-risk genotype encountered. 62,5% of infected women doesn’t show any cytological abnormality on pap smears. Low and High grade epithelial lesions were associated with HPV 16.
Conclusion : There is currently few and sparse data in Tunisia. This work represents to our knowledge the first HPV cervical infection screening study in Tunisia in a basic health centre. The most relevant data is the High frequency of High risk HPV infections related to HPV 16. More than a half of cervical smears in infected women does not show any cytological abnormality and thus, pap smear screening is not appropriated to detect this infection
aim : This study aims to obtain some relevant data on local disease burden in a big health care centre of Tunis.
method : In this study, 133 healthy Tunisian women are screened for HPV infection with detection of 37 genotypes. Samples are collected on dry cotton swabs and genotyping use PCR and linear array assay.
results : 7,8 % of women were infected and HPV 16 was the only High-risk genotype encountered. 62,5% of infected women doesn’t show any cytological abnormality on pap smears. Low and High grade epithelial lesions were associated with HPV 16.
Conclusion : There is currently few and sparse data in Tunisia. This work represents to our knowledge the first HPV cervical infection screening study in Tunisia in a basic health centre. The most relevant data is the High frequency of High risk HPV infections related to HPV 16. More than a half of cervical smears in infected women does not show any cytological abnormality and thus, pap smear screening is not appropriated to detect this infection
Keywords:
Human papillomavirus. Prevalence. Cervical cancer. HPV vaccine##plugins.themes.academic_pro.article.details##
References
- Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infections. J Clin Virol. 2005; 32 Suppl 1: S16-24.
- De Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004; 324:17-27.
- Sandri MT, Riggio D, Salvatici M, et al. Typing of human papillomavirus in women with cervical lesions: prevalence and distribution of different genotypes. J Med Virol 2009; 81: 271-7.
- Clifford GM, Gallus S, Herrero R, Muñoz N, et al. IARC HPV Prevalence Surveys Study Group. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis Lancet. 2005; 366 : 991-8.
- Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 2008; 26 Suppl 10 : K29-41.
- Baseman JG, Kulasingam SL, Harris TG, et al. Evaluation of primary cervical cancer screening with an oncogenic human papillomavirus DNA test and cervical cytologic findings among women who attended family planning clinics in the United States. Am J Obstet Gynecol 2008; 199: 26.e1-8.
- Söderlund-Strand A, Carlson J, Dillner J. A modified general primer PCR system for sensitive A modified detection of multiple types of oncogenic Human Papillomavirus. J Clin Microbiol 2009 ; 47 : 541-6
- Hantz S, Caly H, Decroisette E et al. Comparaison de 2 techniques de détection et de typage des Papillomavirus humains : Hybrid Capture® 2,HPV Consensus kit®. Pathologie et Biologie 2005 ;53:556-562.
- Hantz S, Caly H, Decroisette E et al. Évaluation des performances de trois techniques de détection et de typage des papillomavirus humains : Hybrid Capture® 2, HPV Consensus kit® et Amplicor HPV® = Evaluation of accuracy of three assays for human papillomavirus detection and typing : Hybrid Capture® 2, HPV Consensus kit® and Amplicor HPV®. Pathol Biol 2008, 56 : 29-35
- De Marco F, Houissa-Kchouk F, Khelifa R, Marcante ML. High-risk HPV types in Tunisia. A pilot study reveals an unexpectedly high prevalence of types 58 and 82 and lack of HPV 18 among female prostitutes. J Med Virol 2006 ; 78 : 950-3.
- 11. Hassen E, Remadi S, Chouchane L. Detection and molecular typing of human papillomaviruses: prevalence of cervical infection in the Tunisian central region] Tunis Med. 1999; 77 : 497-502.
- Hassen E, Chaieb A, Letaief M, et al. Cervical human papillomavirus infection in Tunisian women. Infection. 2003; 31:143-8.
- Frega A, Stentella P, De Ioris A, et al. Young women, cervical intraepithelial neoplasia and human papillomavirus: risk factors for persistence and recurrence. Cancer Lett. 2003; 196 : 127-34.
- Calleja-Macias IE, Kalantari M, Bernard HU. Cholinergic signaling through nicotinic acetylcholine receptors stimulates the proliferation of cervical cancer cells: an explanation for the molecular role of tobacco smoking in cervical carcinogenesis? Int J Cancer. 2009; 124 : 1090-6.
- Frega A, Scardamaglia P, Piazze J, et al. Oral contraceptives and clinical recurrence of human papillomavirus lesions and cervical intraepithelial neoplasia following treatment. Int J Gynaecol Obstet. 2008; 100:175-8.